Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wallis

Showing results (81-90 of 332) with videos related to

Pageof 34
Sort By:
JNMA; Journal of the Nepal Medical Association|August 7, 2007
Behcet's Disease : report of a case and review of the literatureS Wallis, J Macierewicz, B M Shrestha
Tuberculosis (Edinburgh, Scotland)|March 27, 2009
Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosisRobert S Wallis, Solange Vinhas, Ernestas Janulionis
Developmental Medicine and Child Neurology|February 1, 1981
School achievement and behaviour of children who were small-for-dates at birthC E Parkinson, S Wallis, D Harvey
Research in Microbiology|May 1, 1992
Macrophages, mycobacteria and HIV: the role of cytokines in determining mycobacterial virulence and regulating viral replicationR S Wallis, J J Ellner, H Shiratsuchi
Anaesthesia and Intensive Care|May 3, 2018
In reply to Castro-Alves and KendallD J Castanelli, S A Wickramaarachchi, S Wallis
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1986
Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigensR S Wallis, H Fujiwara, J J Ellner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2009
Adalimumab treatment of life-threatening tuberculosisRobert S Wallis, Cloete van Vuuren, Samantha Potgieter
Clinics in Chest Medicine|November 21, 2009
Biomarkers of disease activity, cure, and relapse in tuberculosisT Mark Doherty, Robert S Wallis, Alimuddin Zumla
Expert Review of Anti-Infective Therapy|April 3, 2008
Acquired rifamycin resistance: pharmacology and biologyRobert S Wallis, Karin Weyer, P Bernard Fourie
Blood|January 1, 1988
Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophilsM Berger, E M Wetzler, R S Wallis
Pageof 34

Showing results (81-90 of 332) with videos related to

Sort By:
Pageof 34
JNMA; Journal of the Nepal Medical Association|August 7, 2007
Behcet's Disease : report of a case and review of the literatureS Wallis, J Macierewicz, B M Shrestha
Tuberculosis (Edinburgh, Scotland)|March 27, 2009
Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosisRobert S Wallis, Solange Vinhas, Ernestas Janulionis
Developmental Medicine and Child Neurology|February 1, 1981
School achievement and behaviour of children who were small-for-dates at birthC E Parkinson, S Wallis, D Harvey
Research in Microbiology|May 1, 1992
Macrophages, mycobacteria and HIV: the role of cytokines in determining mycobacterial virulence and regulating viral replicationR S Wallis, J J Ellner, H Shiratsuchi
Anaesthesia and Intensive Care|May 3, 2018
In reply to Castro-Alves and KendallD J Castanelli, S A Wickramaarachchi, S Wallis
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1986
Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigensR S Wallis, H Fujiwara, J J Ellner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2009
Adalimumab treatment of life-threatening tuberculosisRobert S Wallis, Cloete van Vuuren, Samantha Potgieter
Clinics in Chest Medicine|November 21, 2009
Biomarkers of disease activity, cure, and relapse in tuberculosisT Mark Doherty, Robert S Wallis, Alimuddin Zumla
Expert Review of Anti-Infective Therapy|April 3, 2008
Acquired rifamycin resistance: pharmacology and biologyRobert S Wallis, Karin Weyer, P Bernard Fourie
Blood|January 1, 1988
Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophilsM Berger, E M Wetzler, R S Wallis
Pageof 34